Minocycline HCl

Moxifioxacin hydrochlodde is one of the two new fluoroquinolonecarboxylic acid antibiotics introduced in 1999 for the treatment of respiratory tract infections such as community-acquired pneumonia, acute exacerbations of bronchitis or acute sinusitis. Moxifloxacin can be synthesized through a 12 step sequence from the classical 4-quinolone-3-carboxylic acid template. Some advantages of Moxifloxacin over Ciprofloxacin, another of Bayer's launched quinolones, have been shown, i.e. an enhanced activity against Gram-positive bacteria (Streptococcus pneumoniae, Clostndium pneumoniae), a favorable pharmacokinetic profile (good tissue penetration and plasma concentrations above MICs) and a lack of phototoxicity (UVA irradiation). 

Moxifloxacin can be used to treat social acquired pneumonia caused by Staphylococcus aureus, influenza bacilli, pneumococcus, acute attack of chronic bronchitis, acute sinusitis, etc. It belongs to the fourth generation of quinolone antibiotics and is a new generation of broad spectrum antibiotics. It has strong antimicrobial activity against common respiratory pathogens such as Streptococcus pneumoniae, Haemophilus, Morahan catarrhalis and some Staphylococcus aureus, especially Streptococcus pneumoniae. It is clinically used to treat acute sinus adenitis, acute exacerbation of chronic bronchitis) community acquired pneumonia, as well as non-complications of skin and soft tissue 

Moxifloxacin Hydrochloride is a fluoroquinolone antibiotic developed by Bayer Pharmaceuticals (Germany.) It can be used to treat community-acquired pneumonia caused by Staphylococcus aureus, baccilus, pneumococcus, mucositis Moraxella, and Klebsiella pneumoniae, acute chronic bronchitis attacks, and acute sinusitis. For the treatment of adult bacterial lung infections, paranasal sinus, skin, and abdominal cavity. Also used to treat community-acquired pneumonia, chronic bronchitis, urogenital infection, and acute sinusitis.

Loaʻa iā mākou nā hale hana kiʻekiʻe me ka pilina hohonu, hiki iā ia ke hāʻawi iā ʻoe i nā huahana kiʻekiʻe a me nā kumukūʻai hoʻokūkū. A hiki iā mākou ke hāʻawi i nā uku no nā kūʻai nui. A ke hui pū nei mākou me nā ʻoihana lawe ukana ʻoihana he nui, hiki ke hāʻawi i nā huahana me ka palekana a me ka maʻalahi i kou mau lima. ʻO ka manawa hoʻouna ma kahi o 3-20 mau lā ma hope o ka hōʻoia ʻana o ka uku.

Minocycline Hydrochloride is a semisynthetic tetracycline class,broad-spectrum antibiotics in the tetracycline class of antibiotics,the product of the strongest activity.To gram-positive bacteria including tetracycline resistance of staphylococcus aureus,streptococcus and gram-negative bacteria such as gonorrhea netheril bacteria have a strong role; For chlamydia trachomatis and dissolving urea mycoplasma also has better inhibition.

1. He hale hana ʻoe a he hui kālepa paha?
He compnay mākou e hoʻohui i ka ʻoihana a me ke kālepa, e hāʻawi ana i ka lawelawe hoʻokahi. Hiki ke ʻae ʻia ʻo OEM.

2. Hāʻawi anei ʻoe i nā laʻana? He manuahi a keu paha?
Free samples.The sample's freight fee Pono e uku ma kou aoao.

3. Loaʻa iā ʻoe nā palapala hōʻoia e pili ana i ka mana maikaʻi?
ISO 9001: 2008 palapala hōʻoia e hōʻoia i ka maikaʻi.

4. He aha kaʻu e hāʻawi ai e kiʻi i kahi ʻōlelo?
E haʻi mai ʻo Pls iā mākou i ke ʻano huahana āu e pono ai, ka nui o ke kauoha, ka helu a me nā koi kikoʻī. E hana ʻia ka ʻōlelo no kāu kuhikuhi i ka manawa.

5. He aha ke ʻano o ka uku uku āu e makemake ai? He aha ke ʻano o nā ʻōlelo i ʻae ʻia?
ʻAe ʻia nā ʻōlelo hoʻouna: FOB, CFR, CIF, EXW;
ʻAe ʻia ke kālā uku:USD;
ʻAno uku i ʻae ʻia: T / T, Western Union; Paypal, Hōʻoia Kūʻai.
ʻŌlelo i ʻōlelo ʻia: English.